Get the Stockscreener App
65.51
3.32%
-2.25
After Hours:
65.50
-0.01
-0.02%
Hologic Inc stock is traded at $65.51, with a volume of 2.10M.
It is down -3.32% in the last 24 hours and up +1.64% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$67.76
Open:
$67.14
24h Volume:
2.10M
Relative Volume:
1.15
Market Cap:
$14.57B
Revenue:
$4.04B
Net Income/Loss:
$557.10M
P/E Ratio:
27.18
EPS:
2.4102
Net Cash Flow:
$916.70M
1W Performance:
-2.72%
1M Performance:
+1.64%
6M Performance:
+13.24%
1Y Performance:
-17.92%
1-Day Range:
$65.41
$67.99
1-Week Range:
$65.41
$68.98
52-Week Range:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
65.51 | 15.07B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
435.73 | 154.00B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
186.66 | 53.47B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
273.01 | 39.70B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
72.60 | 35.62B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
262.47 | 18.82B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Using fundamentals and technicals on Hologic Inc.Weekly Loss Report & Real-Time Volume Analysis - newser.com
Real time breakdown of Hologic Inc. stock performanceIndex Update & Consistent Growth Equity Picks - newser.com
Short interest data insights for Hologic Inc.Trade Risk Assessment & Smart Allocation Stock Tips - newser.com
Statistical indicators supporting Hologic Inc.’s strengthWall Street Watch & Free Community Supported Trade Ideas - newser.com
Best data tools to analyze Hologic Inc. stockJuly 2025 Trends & Low Risk Profit Maximizing Plans - newser.com
Body Fat Measurement Market Poised for Growth, Expected to Hit - openPR.com
Will Hologic Inc. rebound enough to break evenJuly 2025 Macro Moves & Daily Growth Stock Tips - newser.com
Hologic (HOLX) Stock Moves -1.25%: What You Should Know - sharewise.com
Hologic Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Pattern recognition hints at Hologic Inc. upside2025 Price Action Summary & Long-Term Growth Plans - newser.com
Is Hologic Inc. stock a buy before product launchesJobs Report & Verified Swing Trading Watchlist - newser.com
What the charts say about Hologic Inc. todayJuly 2025 Short Interest & Weekly Top Gainers Alerts - newser.com
Infectious Disease Testing Product Market 2025 | Industry - openPR.com
Can Hologic Inc. recover in the next quarterPortfolio Performance Summary & Low Risk Entry Point Guides - newser.com
Is Hologic Inc. stock trading near support levelsRate Cut & Weekly Breakout Watchlists - newser.com
Risk adjusted return profile for Hologic Inc. analyzedDip Buying & Stepwise Trade Signal Implementation - newser.com
Tools to assess Hologic Inc.’s risk profileFed Meeting & Weekly High Return Stock Forecasts - newser.com
Live market analysis of Hologic Inc.Trade Volume Report & Weekly Return Optimization Alerts - newser.com
Hologic, Inc. Hits Day High with 7.69% Surge in Stock Price - Markets Mojo
What Hologic (HOLX)'s FDA Clearance for GI Assays Means for Shareholders - Yahoo Finance
Hologic Expands Panther Fusion's Menu With Diagnostic Innovation - Yahoo Finance
3 Reasons HOLX is Risky and 1 Stock to Buy Instead - The Globe and Mail
Evercore ISI Group Upgrades Hologic (HOLX) - Nasdaq
Hologic (HOLX) Upgraded to Outperform by Evercore ISI Group | HO - GuruFocus
Hologic (HOLX) Shares Climb After Upgrade by Evercore ISI - GuruFocus
Evercore ISI Upgrades Hologic to Outperform From In Line, Adjusts Price Target to $78 From $69 - MarketScreener
Good practices post-Minerva Surgical, Inc. v. Hologic, Inc. | Latin America | Global law firm - Norton Rose Fulbright
What to do if you’re stuck in Hologic Inc.Earnings Overview Summary & AI Powered Market Entry Ideas - newser.com
How to Play HOLX Stock This Breast Cancer Awareness Month? - The Globe and Mail
How Hologic Inc. (HO1) stock reacts to monetary easingEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Technical analysis overview for Hologic Inc. stock2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Will Dual FDA and CE Approvals for Panther Fusion Shape Hologic's (HOLX) Long-Term Story? - simplywall.st
What dividend safety rating applies to Hologic Inc. (HO1) stockWeekly Trend Summary & Weekly Top Gainers Alerts - newser.com
Should I buy Hologic Inc. (HO1) stock before earnings seasonPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Greenleaf Trust Purchases 173 Shares of Hologic, Inc. $HOLX - Defense World
Chart based analysis of Hologic Inc. trendsTake Profit & Fast Momentum Entry Tips - newser.com
Key metrics from Hologic Inc.’s quarterly dataJuly 2025 Levels & Proven Capital Preservation Tips - newser.com
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests - MSN
HOLXNew Survey Results Underscore the Need to #BustTheMyth About Mammograms - ADVFN Ltd
Farther Finance Advisors LLC Increases Stock Position in Hologic, Inc. $HOLX - Defense World
User - FinancialContent
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Hologic Inc Stock (HOLX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| MACMILLAN STEPHEN P | Chairman, President and CEO |
Sep 22 '25 |
Sale |
66.97 |
138,358 |
9,266,118 |
1,234,624 |
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):